MLPClinical Trials•prnewswire•September 10, 2025 at 08:15 PM

Endo Presents Plantar Fibromatosis and Plantar Fasciitis Data at the American Orthopaedic Foot & Ankle Society Annual Meeting

Sentiment:Negative (30)

Summary

(NYSE:MLP) MALVERN, Pa., Sept. 10, 2025 /PRNewswire/ -- Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that two presentations related to plantar fibromatosis (PFI) and plantar fasciitis (PFA) will be shared during the American Orthopaedic Foot & Ankle Society Annual Meeting,...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 10, 2025 by prnewswire